Doxycycline Injection Indications
Doxycycline injection (IV/IM) is indicated for a broad range of bacterial infections including rickettsial diseases, atypical pneumonias, sexually transmitted infections, gram-negative and gram-positive bacterial infections when susceptible, and as post-exposure prophylaxis for inhalational anthrax. 1
FDA-Approved Indications for Injectable Doxycycline
The FDA label provides the authoritative list of approved indications for doxycycline injection 1:
Rickettsial and Atypical Infections
- Rickettsial infections: Rocky Mountain spotted fever, typhus fever, Q fever, rickettsialpox, and tick fevers
- Mycoplasma pneumoniae (atypical pneumonia)
- Psittacosis and ornithosis agents
- Lymphogranuloma venereum and granuloma inguinale
- Relapsing fever (Borrelia recurrentis)
Gram-Negative Bacterial Infections
- Haemophilus ducreyi (chancroid)
- Yersinia pestis (plague)
- Francisella tularensis (tularemia)
- Bartonella bacilliformis
- Bacteroides species
- Vibrio cholerae
- Campylobacter fetus
- Brucella species (in conjunction with streptomycin)
When susceptibility is confirmed:
- Escherichia coli
- Enterobacter aerogenes
- Shigella species
- Acinetobacter species
- Haemophilus influenzae (respiratory infections)
- Klebsiella species (respiratory and urinary infections)
Gram-Positive Bacterial Infections (When Susceptible)
- Streptococcus species (when demonstrated sensitive—note: up to 44% of S. pyogenes and 74% of S. faecalis may be resistant)
- Streptococcus pneumoniae
- Staphylococcus aureus (respiratory, skin, and soft tissue infections—though not first-line for staphylococcal infections)
Specific High-Priority Indications
- Inhalational anthrax (Bacillus anthracis): Post-exposure prophylaxis to reduce incidence or progression after aerosolized exposure
- Acute intestinal amebiasis: As adjunct to amebicides
When Penicillin is Contraindicated
- Neisseria gonorrhoeae and N. meningitidis
- Treponema pallidum (syphilis and yaws)
- Listeria monocytogenes
- Clostridium species
- Fusobacterium fusiforme (Vincent's infection)
- Actinomyces species
Other Indications
- Trachoma (though infectious agent not always eliminated)
Critical Clinical Considerations
Resistance Patterns Matter
Culture and susceptibility testing are strongly recommended before using doxycycline injection, particularly for gram-negative and gram-positive organisms where resistance rates are significant 1. Many strains show resistance, making empiric use risky without local susceptibility data.
Not First-Line for Common Infections
- Streptococcal infections: Penicillin remains the drug of choice for group A beta-hemolytic streptococci, including rheumatic fever prophylaxis 1
- Staphylococcal infections: Tetracyclines are explicitly not drugs of choice for any staphylococcal infection 1
Route Selection
Injectable doxycycline achieves comparable serum concentrations to oral administration, and oral absorption is rapid and virtually complete 2. The IV/IM route should be reserved for patients unable to take oral medications or when rapid therapeutic levels are critical, as oral bioavailability is excellent even with food 2, 3.
Dosing Advantage
The prolonged half-life (approximately 12 hours) allows once-daily administration, and doxycycline does not accumulate in renal insufficiency, requiring no dose adjustment 2.
Common Pitfalls to Avoid
- Do not use for streptococcal disease without documented susceptibility—resistance rates are too high 1
- Do not choose doxycycline as first-line for staphylococcal infections—other agents are superior 1
- Do not assume susceptibility for gonorrhea—elevated antimicrobial resistance makes it unsuitable as treatment, though it may prevent some strains 4
- Do not use IV route when oral is feasible—bioavailability is equivalent and oral administration avoids infusion-related complications 2